What is the Pangen Biotech Inc. stock price forecast?

Pangen Biotech Inc. is currently trading at ₩4,795. View real-time AI analysis on Alpha Lenz.

What is Pangen Biotech Inc. insider trading activity?

View the latest insider trading data for Pangen Biotech Inc. on Alpha Lenz.

What is Pangen Biotech Inc.'s P/E ratio?

Pangen Biotech Inc.'s P/E ratio is 31.8.

Pangen Biotech Inc.

KRX · 222110

₩4,795-35(-0.72%)Market closed

Ask about Pangen Biotech Inc.'s future dividend policy...

Alpha Chat Insight

“Pangen Biotech Inc. trades at a P/E of 31.8 (premium valuation) with modest ROE of 7.5%. 3Y revenue CAGR of 27.3% highlights clear growth momentum.”

Ask for details →

Company Overview

Pangen Biotech Inc. is a company focusing on the biotechnology sector, where it engages in the research, development, and production of therapeutic proteins and biologics. The primary purpose of the company is to harness advanced technologies in protein engineering and biologics to develop treatments for various diseases. Notable features of Pangen Biotech Inc. include its state-of-the-art facilities that cater to high-precision biotechnology processes and its emphasis on personalized medicine. The company plays a significant role in the healthcare industry, particularly in areas related to drug development and innovation. By concentrating on biotechnology solutions, Pangen Biotech Inc. contributes to the evolution of medical treatments and therapies, impacting both the scientific community and patient health outcomes worldwide.

CEO윤재승

Websitehttps://www.pangen.com

SectorHealthcare

IndustryBiotechnology

Company Statistics

FY 2025

Profile

₩65,275,078,470Market Cap

₩13,416,632,780Revenue

13.51MShares Out

0Employees

Margins

33.61%Gross

25.54%EBITDA

11.23%Operating

15.41%Pre-Tax

15.28%Net

Valuation

31.83P/E

2.18P/B

4.87EV/Sales

18.24EV/EBITDA

-119.20P/FCF

Growth (CAGR)

27.32%Rev 3Yr

16.73%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

6.48%ROA

7.48%ROE

7.00%ROIC

Financial Health

₩3,755,830,800Cash & Cash Equivalents

₩-979,674,650Net Debt

9.28%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Pangen Biotech Inc. trades at a P/E of 31.8 (premium valuation) with modest ROE of 7.5%. 3Y revenue CAGR of 27.3% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Pangen Biotech Inc. (ticker: 222110) is a company listed on KRX in the Healthcare sector (Biotechnology). Market cap is $65.3B.

The current price is ₩4,795 with a P/E ratio of 31.83x and P/B of 2.18x.

ROE is 7.48% and operating margin is 11.23%. Annual revenue is $13.4B.